Traphaco JSC (HOSE:TRA)

Vietnam · Delayed Price · Currency is VND

37,000

+500 (1.37%)

At close: Aug 28, 2026

10.12% (1Y)

Market Cap	3.07T +10.1%
Revenue (ttm)	2.77T +13.4%
Net Income	222.09B +13.0%
EPS	2,678.98 +10.2%
Shares Out	82.90M
PE Ratio	13.81
Forward PE	n/a
Dividend	3,000.00 (8.11%)
Ex-Dividend Date	Jul 21, 2026

Volume	971
Open	36,250
Previous Close	36,500
Day's Range	36,000 - 37,000
52-Week Range	31,500 - 41,400
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals,... [Read more]

Industry Pharmaceutical Preparations

Founded 1972

Employees 1,546

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol TRA

Full Company Profile

Financial Performance

In 2025, Traphaco JSC's revenue was 2.66 trillion, an increase of 13.21% compared to the previous year's 2.35 trillion. Earnings were 216.79 billion, an increase of 4.98%.

Financial Statements